Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07425340

Ultrasound Examination of the VMO in Patellofemoral Pain Syndrome

The aim of this study is to examine in detail the ultrasonographic characteristics of the vastus medialis obliquus and vastus medialis longus muscles in individuals with patellofemoral pain syndrome and to compare these findings with those of healthy individuals. It is anticipated that the results obtained will contribute to a better understanding of the muscle-based mechanisms of PFAS and provide a scientific basis for the development of muscle-specific assessment and intervention strategies in physical therapy and rehabilitation practices.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Hasan Kalyoncu University

Gaziantep, Şahinbey, (505) 090-5846, Turkey (Türkiye)

About this study

Patellofemoral pain syndrome (PFAS) is a musculoskeletal problem characterized by pain in the front of the knee joint, commonly seen in young and physically active individuals. The etiology of PFAS is multifactorial and is associated with abnormal loading of the patella within the femoral trochlear groove, alterations in joint biomechanics, and functional deficiencies of the surrounding soft tissues. These mechanical irregularities in the patellofemoral joint can lead to pain, loss of function, and activity limitations over time. The quadriceps femoris muscle group plays a fundamental role in providing dynamic stability to the patella. The vastus medialis obliquus (VMO) and vastus medialis longus (VML) muscles within this muscle group are critical for controlling the patella medially and maintaining its proper alignment within the femoral groove. It is known that the oblique fiber structure of the VMO muscle provides medial stabilizing force to the patella, while the VML muscle contributes to force production during knee extension and overall patellar guidance with its longer fibers. In individuals with PFAS, delayed activation patterns, decreased muscle strength, and morphological changes in the vastus medialis muscle have been reported. However, it is observed in the literature that the VMO and VML muscles are treated as a single structure in most studies, and the separate morphological characteristics of these two muscles and their relationship with patellofemoral pain have not been sufficiently investigated. However, the different anatomical, biomechanical, and functional characteristics of these muscles necessitate that their roles in PFAS pathophysiology be evaluated separately. Ultrasonography is a non-invasive, reliable, and reproducible imaging method for evaluating the morphological characteristics of muscle tissue and is increasingly used in clinical research. Ultrasonographic evaluation allows for the objective examination of muscle thickness, cross-sectional area, and architectural features, thereby providing important information about structural changes in muscle function. The aim of this study is to examine in detail the ultrasonographic characteristics of the vastus medialis obliquus and vastus medialis longus muscles in individuals with patellofemoral pain syndrome and to compare these findings with healthy individuals. It is anticipated that the results will contribute to the understanding of the muscle-based mechanisms of PFAS and provide a scientific basis for the development of muscle-specific assessment and intervention strategies in physical therapy and rehabilitation practices.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Between the ages of 18 and 65
  • Have had localized pain in the front of the knee for at least the past 3 months
  • Experience pain during activities that require stair climbing, squatting, prolonged sitting, or knee flexion
  • Have been diagnosed with patellofemoral pain syndrome based on clinical evaluation
  • Volunteer to participate in the study and sign the informed consent form

Exclusion criteria

  • History of previous surgery on the knee joint
  • History of significant trauma to the knee region within the last 6 months
  • Diagnosis of meniscus, ligament injuries, knee osteoarthritis, or inflammatory rheumatic disease
  • Neurological diseases or systemic diseases affecting the musculoskeletal system
  • Presence of other lower extremity pathologies causing pain at a level that could affect measurements

Treatment and study plan

Primary outcomes

  1. Ultrasonographic Measurement

    Time frame: through of the study, average 4 months

    A B-mode ultrasound device with a high-frequency (7-12 MHz) linear probe will be used to evaluate muscle architecture. Ultrasound is a reliable, reproducible, and non-invasive imaging method for assessing the morphological characteristics of muscle tissue. Ultrasonographic evaluations will be performed by an experienced researcher in musculoskeletal ultrasonography, in a quiet and standard environment. A high-frequency (7-12 MHz) linear probe will be used during measurements. Participants will be placed on the evaluation table in a supine position, with the knee joint fully extended and relaxed. Before measurements, anatomical reference points will be determined using a tape measure, and temporary markings will be made on the skin. Vastus Medialis Obliquus (VMO): VMO muscle thickness measurement will be performed in the region where the oblique orientation of the muscle fibers is prominent, using the upper-medial edge of the patella as a reference. The measurement point will be determ

Study contacts

Contact information is provided by the study sponsor or research team.

Tuğba GÖNEN, Asisst. Prof. Dr.

CONTACT

[email protected]

505 090 58 46

Sponsors and collaborators

Lead sponsor

Hasan Kalyoncu University

Other

Registry information

Official study title

Ultrasonography Examination of the Vastus Medialis Obliquus and Vastus Medialis Longus Muscles in Patellofemoral Pain Syndrome

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Feb 20, 2026
Registry last updated
Feb 20, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.